UPBD Q1 2026 Earnings EPS Beats Estimates Stock Rises Slightly SKYE Q1 2026 Earnings EPS Slightly Below Estimates Stock Surges 16 on Strategic Progress TWAV Q3 2022 Earnings Steep EPS Miss Raises Concerns Over Profitability AKTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development UUUU Q1 2026 Earnings EPS Beat Helps Shares Edge Higher Despite No Revenue Reported